Findings of a phase 2 trial with aldosteron synthase inhibitor in hypertension - PACE-CME

Findings of a phase trial with aldosteron synthase inhibitor in hypertension

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Do personalized reminders to clinicians result in higher use of high-intensity statins?
Do personalized reminders to clinicians result in higher use of high-intensity statins?
ACC.23
Do personalized reminders to clinicians result in higher use of high-intensity statins?
- Prof. Salim Virani, MD, PhD
Interesting developments in the field of PCSK9 inhibition
Interesting developments in the field of PCSK9 inhibition
ACC.23
Interesting developments in the field of PCSK9 inhibition
- Deepak Bhatt, MD
Implementing precision health for public health using causal AI
Implementing precision health for public health using causal AI
ACC.23
Implementing precision health for public health using causal AI
- Ami Bhatt, MD
Causal AI can substantially improve the value of polygenic risk score for CVD
Causal AI can substantially improve the value of polygenic risk score for CVD
ACC.23
Causal AI can substantially improve the value of polygenic risk score for CVD
- Prof. Brian Ference, MD